Solesence, Inc. Common Stock
NASDAQ:SLSNHousehold & Personal Products
+$0.05 today
- Market cap
- $115.86M
- Beta
- 1.24
- P/E (TTM)
- 99.5
- EPS (TTM)
- $0.01
Volume 0.30M
Average 0.04M
SLSN Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Solesence, Inc. Common StockNASDAQ: SLSN
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables falls 29.8% from a year ago
Net receivables stood at $6.38M at the end of Q1 FY2026, down 29.8% from a year earlier and down 6.7% from the prior quarter. Over 3 fiscal years it compounded at +13.0% a year.
Context
- Net receivables amounted to 13.3% of total assets at the end of Q1 FY2026, down 2.6 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -29.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 6.84M USD
- Year-over-year change
- +40.4%
- 4-year CAGR
- +14.8%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.84M | +40.4% |
| FY2024 | 2024-12-31 | 4.87M | +40.4% |
| FY2023 | 2023-12-31 | 3.47M | -26.8% |
| FY2022 | 2022-12-31 | 4.73M | +20.2% |
| FY2021 | 2021-12-31 | 3.94M | — |
Net Receivables vs competitors
How SLSN compares with its peers on the latest reported figures
- SLSN's Mar 2026 net receivables of $6.38M is the 7th highest of the 8 companies compared; the peer median is $14.48M.
- Its year-over-year change of -29.8% is the 6th highest of 8, against a peer median of -13.9%.
- Net receivables amounts to 13.3% of total assets for SLSN, versus a peer median of 4.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $33.51M | +8.8% | -3.7% | 17.2% | |
AFRIForafric Global PLC | Dec 2024 | $26.19M | -52.2% | -35.4% | 10.6% |
| Mar 2026 | $20.25M | -13.9% | -33.0% | 4.3% | |
| Apr 2026 | $14.48M | -27.9% | +0.6% | 4.9% | |
| Mar 2026 | $12.55M | +10.0% | -15.2% | 4.8% | |
| Mar 2026 | $7.78M | +188.8% | +131.7% | 7.5% | |
SLSNSolesence, Inc. Common Stock | Mar 2026 | $6.38M | -29.8% | +13.0% | 13.3% |
| Mar 2026 | $2.19M | -80.2% | -2.1% | 1.1% | |
| Peer median (excluding SLSN) | $14.48M | -13.9% | -3.7% | 4.9% | |
Competitors are the stored peer set for SLSN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 657K | 2.19M | 1.72M | 1.41M | 1.29M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.94M | 4.73M | 3.47M | 4.87M | 6.84M |
| Inventory | 6.1M | 8.84M | 10.03M | 20.27M | 18.51M |
| Other Current Assets | 0 | 866K | 1.08M | 2.8M | 2.14M |
| Total Current Assets | 11.6M | 16.63M | 16.3M | 29.35M | 28.78M |
| Property, Plant & Equipment (Net) | 16.79M | 16.93M | 16.58M | 20.65M | 6.91M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 8K | 6K | 4K | 3K | 14.37M |
| Total Non-current Assets | 16.8M | 16.93M | 16.58M | 20.65M | 21.28M |
| Total Assets | 28.39M | 33.56M | 32.88M | 50M | 50.06M |
| Account Payables | 3.89M | 6.77M | 6.39M | 10.69M | 4.39M |
| Short-term Debt | 1.35M | 4.28M | 4.81M | 5M | 4.77M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 905K | 2.23M | 2.35M | 5.57M | 930K |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 7.34M | 13.84M | 15.59M | 25.77M | 13.93M |
| Long-term Debt | 1M | 4M | 6M | 0 | 10.5M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 661K | 21K | 0 | 0 | 0 |
| Other Non-current Liabilities | 222K | 230K | 238K | 246K | 194K |
| Total Non-current Liabilities | 13.59M | 14.07M | 15.39M | 9.28M | 18.49M |
| Total Liabilities | 20.93M | 27.91M | 30.98M | 35.06M | 32.42M |
| Common Stock | 489K | 493K | 496K | 700K | 706K |
| Retained Earnings | (97.45M) | (100.07M) | (104.66M) | (100.43M) | (98.64M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7.47M | 5.65M | 1.9M | 14.95M | 17.63M |
| Total Debt | 14.75M | 18.11M | 21.26M | 15.3M | 24.32M |
| Net Debt | 14.09M | 15.92M | 19.54M | 13.89M | 23.03M |
Solesence, Inc. Common Stock
NASDAQ:SLSN
Intrinsic Alpha fair value
Locked
Current Price
$1.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.